Altamira Therapeutics Ltd. Gains 36.7%

Fri, Mar 11, 2022 at 05:30 PM
Altamira Therapeutics Ltd. Gains 36.7%

Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $0.94, representing a gain of 36.7%. On Thu, Mar 10, 2022, CYTO:NASDAQ touched a New 2-Week Low of $0.69. The stock got featured on our News Catalysts scanner on Fri, Mar 11, 2022 at 09:58 AM in the 'MISCELLANEOUS' category. From Fri, Feb 25, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days

The stock spiked on Wed, Dec 29, 2021 at $2.3 with a volume of 23M+.

About Altamira Therapeutics Ltd. (CYTO:NASDAQ)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.